Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group

OBJECTIVE: The Osteoarthritis Research Society International initiated a number of working groups to address a call from the US Food and Drug Administration (FDA) on updating draft guidance on conduct of osteoarthritis (OA) clinical trials. The development of disease-modifying osteoarthritis drugs (...

Full description

Saved in:
Bibliographic Details
Main Authors: Conaghan, P.G., Hunter, D.J., Maillefert, J.F., Reichmann, W.M., Losina, E.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260466/
https://ncbi.nlm.nih.gov/pubmed/21396466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2011.02.018
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items